Background Atopic dermatitis is an allergic T-cell mediated skin inflammation. Staphylococcus aureus colonization is very common in cutaneous atopic dermatitis lesions. The cutaneous lymphocyte-associated antigen (CLA) is a T cell skin homing receptor that defines T lymphocytes associated with the cutaneous immune response. Objective To study whether CLA þ T cells from atopic dermatitis children present a selective expression for Staphylococcus aureus-related TCR Vb segments. Methods Peripheral blood T cells were stained with HECA-452 (anti-CLA) and a panel of TCR Vb specific monoclonal antibodies and analysed by flow cytometry. Results Atopic dermatitis patients have a higher percentage of circulating CLA þ CD3
Introduction
The cutaneous lymphocyte-associated antigen (CLA) is a skin homing receptor for human T cells [1, 2] . Most T lymphocytes infiltrating the skin in different inflammatory processes are positive for CLA, whereas this antigen is not expressed in T cells present in other inflamed tissues [1] .
Leucocyte extravasation into tissues is a multistep process involving several adhesion molecules and chemokines [3] . It has been shown that the inducible endothelial cell ligand E-selectin (CD62E) mediates adhesion [4, 5] and transendothelial migration of CLA þ T cells [6] and the IL-8 receptor B is preferentially involved in such CLA þ T cell migration in vitro [7, 8] . The cutaneous immune response is associated with a circulating population of CLA þ T cells, as has been demonstrated for atopic and contact dermatitis [9] .
Atopic dermatitis (AD) is a chronic cutaneous inflammatory disease with marked T-cell infiltration [10] . It has been reported that in some AD patients skin lesion-derived T-cell clones react to Dermatophagoides pteronyssinus allergen and produce a TH 2 cytokine pattern profile [11] , and moreover, they express CLA [12] . Patients with AD frequently develop cutaneous infections. Over 90% of AD patients suffer from cutaneous Staphylococcus aureus (Sa) infections [13] , many of them developing IgE antibodies against Sa [14, 15] , while anti-staphylococcal antibiotics reduce the clinical manifestations of affected subjects [16] . These findings suggest a relationship between AD pathology and Sa infection [10] .
Bacterial superantigens (superAgs) bind to human MHCclass II bearing cells. This complex stimulates T cells expressing specific TCR Vb chain segments [17] . Several studies have analysed the effects of Sa superAgs on in vitro responsiveness of peripheral blood mononuclear cells (PBMC) from AD patients [18] [19] [20] [21] . lnterestingly Sa superAg activation of human PBMC induces expression of CLA via stimulation of IL-12 production [22] .
In order to characterize further the influence of Sa infection in AD we have analysed the expression of a limited number of TCR Vb segments in circulating CLA þ T cells from subjects with AD. Our results indicate that circulating CLA þ T lymphocytes from patients with active AD contain an increased percentage of cells expressing TCR Vb5.1 and Vb2, both of which are Sa superAg-specific TCR Vb elements.
Methods

Subjects
A group of children with AD according to the criteria of Hannifin and Rajka [23] and with symptoms at the moment of evaluation formed the active AD group (n ¼ 12). A second group of children with AD but no symptoms at the moment of the evaluation were included as a non-active AD group (n ¼ 8). The control group was formed by children with no AD and no history of any allergic disease (n ¼ 8).
The three groups were age-and sex-matched. Sa was detected in skin lesions of 66% of the patients from the active AD group but was present in none of the control group or non-active AD group. Cutaneous tests were performed by skin prick tests to inhalant and food allergens. The total IgE test was performed using Cap-FEIA system from Pharmacia (Uppsala, Sweden).
Monoclonal antibodies
The HECA-452 MoAb was kindly provided by L. J. Picker [1] . The anti-CD3, anti-Vb2, -Vb3, -Vb5.1, -Vb11 and -Vb17 MoAbs were conjugated to FITC and anti-HLA-DR conjugated to PE-Cy5, all obtained from Immunotech (Marseille, France). Goat anti-rat IgM (chain specific) conjugated to PE was from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PE, USA). Isotype controls used included: mouse IgM, IgG1, and IgG2a conjugated to PE-Cy5; all purchased from Immunotech. Rat IgM was purchased from Jackson ImmunoResearch Laboratories Inc., and was used as an isotype control for the HECA-452 MoAb.
Cell staining and flow cytometry analysis
PBMC were isolated from heparinized venous blood by Ficoll density gradient (Nycomed As, Oslo, Norway), and stained as previously described [24] . Briefly, 105 lymphocytes were sequentially stained with HECA-452, goat anti-rat PE-conjugated, normal mouse serum, CD3-FITC or Vbs-FITC and HLA-DR-PE-Cy5 to study CLA/CD3/HLA-DR expression. To study CLA/Vb/HLA-DR expression the same number of cells were sequentially stained with HECA-452, goat anti-rat PE-conjugated, normal mouse serum, Vbs-FITC and HLA-DR-PE-Cy5. All steps were performed at 4ЊC. Stained cells were fixed in 1% paraformaldehyde in PBS and stored at 4 ЊC until analysis.
Five-parameter analysis was performed on an Ortho Cytoron Absolute flow cytometer equipped with an argon laser that was operated at 488 nm, with green, orange and red fluorochromes used as the three fluorescent parameters. FITC emissions were measured with 510/550 band pass filter, PE with 550/600 and PE-Cy5 with > 600 long band pass filter, respectively. List mode multiparameter data files were analysed with an Ortho Immunocount System Software. Isotype control MoAbs were used to verify specific staining.
Statistical analysis
Statistical analysis was performed using the SPSS program. 
Kruskall-Wallis and Mann-Whitney tests for non-parametric values. Data are expressed as the medians and interquartile ranges (IR).
Results
Expression of CLA on circulating T lymphocytes
The percentage of CD3 þ CLA þ cells was determined for the three groups of patients as shown in Fig. 1 . The active AD group showed the highest percentage of CLA þ CD3 þ with a median value of 16.82 and an IR 12.69-22.50. This was significantly different from the control group, median 10.99, IR 9.29-12.91 (P < 0.01). The median of CLA þ T cells in the non-active group was 15.25, IR 13.27-17.11 and was also significantly different from the control group (P < 0.02). When the active and non-active AD groups were compared, no significant difference was found.
When we correlated the degree of Sa infections with the percentage of circulating CLA þ CD3 þ cells we found a positive result with a Spearman Correlation Coefficient of 0.6144 and a P-value of 0.034.
Expression of HLA-DR by CD3
þ 
Expression of Vbs on circulating CD3
þ CLA þ and CD3
Study of the expression of several TCR Vbs in circulating lymphocytes by flow cytometry showed a higher expression of Vb2 and Vb5.1 in the CLA þ population from patients with active atopic dermatitis, Fig. 3(a) .
In the active AD group median values and IR for the percentage of CLA þ Vb2 þ were 5.53 (4.66-6.94). This median value was 22.1% higher than the control group which had a median of 4.31 [3.76-4 .74] and 25% higher than the non-active AD group with a median of 4.15 [3.52-4 .41], both differences being statistically significant (P < 0.01).
Evaluation of the TCR Vb5.1 expression in the active AD patients showed a median value of 5.8 [5.15-7 (Fig. 3a) and CLA ¹ cells (Fig. 3b) . (Fig. 4a) and CLA ¹ cells (Fig. 4b) Fig. 3(a),(b) . No correlation was found between CLA and TCR Vb5.1 or TCR Vb2 expression and Sa infection within the active AD group as shown in Table 1 .
Co-expression of HLA-DR and TCR Vbs on circulating CLA
þ lymphocytes A higher expression of HLA-DR was found in the CLA þ Vb5.1 þ , Fig. 4(a) . The active AD group expressed a median value of 3.93 [3.10-4 .60] which was significantly higher (P < 0.001) than the control group median of 1. Fig. 4(a,b) . No correlation was found between CLA, TCR Vb5.1, HLA-DR expression and Sa infection within the active AD group (Table 1) .
Discussion
As expected, there was a significant increase in the percentage of circulating CLA þ T cells in patients with active or non-active AD when compared with healthy controls. When we analysed the surface expression of a limited number of TCR Vb segments (Vb2, Vb3, Vb5.1, Vb11 and Vb17) in both CLA þ and CLA ¹ populations those children with active AD expressed an increased percentage of CLA þ Vb2 and CLA þ Vb5.1 cells in peripheral blood when compared with CLA ¹ cells of the same patients or CLA þ and CLA ¹ from patients with non-active AD or healthy controls. Furthermore, when we analysed the co-expression of HLA-DR and TCR Vbs on circulating CLA þ lymphocytes the only significant increase was found in the CLA þ HLA-DR þ TCRVb5.1 þ cells in those patients with active AD.
Cutaneous lesions from AD patients presented Sa infections in most cases. Since Sa superAgs bind selectively to certain TCR Vb segments, we investigated the surface expression of a limited number of TCR Vb segments in peripheral blood lymphocytes from children with AD (active and non-active) and healthy controls using flow cytometry. In particular we studied their expression within the circulating skin homing T-cell population defined by the CLA antigen [5] because this surface marker distinguishes skin homing T lymphocytes which are functionally associated with the cutaneous immune response [9] . We decided to evaluate these markers in peripheral blood cells rather than skin biopsies because we were studying children and this technique is less aggressive and enables the procurement of more samples for further study. Due to a permanent trafficking of T cells, activated or non-activated cells expressing the markers evaluated can be detected in peripheral blood. However, we are unable to know where the activation and expression of these markers took place, either in the skin or elsewhere.
Several studies have investigated the effects of Sa superAgs in the activation and response of lymphocytes from AD patients [18] [19] [20] [21] . With regards to the role of Sa superAgs in perpetuating dermatitis, it has recently been published that survivors of toxic shock syndrome show an increased frequency of AD [25] and also that the cutaneous application of staphylococcal enterotoxin B induces dermatitis [26] . These facts suggest a role for Sa infection in the immune basis of AD [10] . In our study we only found a positive correlation between the degree of infection and the percentage of circulating CLA þ CD3 þ cells in the group of patients with both active AD and Sa infection.
T lymphocytes expressing CLA are involved in the pathogenesis of AD, and skin-homing T cells from these patients preferentially reacted to Dermatophagoides pteronyssinus extract and spontaneously secreted IL-4 but not IFNg [9, 10] . Different studies have shown that circulating skin-homing T lymphocytes can give information on effector function of T cells located in the skin [27, 28] . Moreover, it has been shown that CLA þ T cells migrate through the supervicial vascular plexus in a hu-SCID mouse graft model grafted with human skin [29] . Also, after patch test-elicited cutaneous inflammation an enhanced expression of E-selectin, ICAM-1 and VCAM-1 correlate with infiltration of CD45R0 þ CLA þ T cells [30] . In our study we found the CLA þ CD3 þ T cells from patients with active and non-active AD expressed higher percentages of HLA-DR þ cells compared with controls. Although the highest values were expressed in AD patients, these differences were not statistically significant, probably due to the low number of patients.
To our knowledge this is the first study to analyse TCR Vbs segment expression in circulating skin-homing T cells in human skin inflammation. Although the number of different TCR Vbs analysed is low, our data indicate a preferential use of Vb2 and Vb5.1 by skin-homing T cells in active AD. This finding may be due to two mechanisms. First, because AD is an allergic skin disorder, the increased expansion of CLA þ T cells with a preferential use for a certain TCR Vb may be related to an allergen-induced expansion. Interestingly, in vitro assays with PBMC from patients with milk-induced eczema demonstrated that casein can expand populations of CLA þ T cells [31] . A second interpretation may relate to a bacterial superAg-induced expansion of CLA þ T cells. It has recently been reported that Sa superAgs can induce in vitro the expression of CLA via stimulation of IL-12 production [22] . In this case, it would be important to know which Sa superAgs are found in the skin of the patients studied.
In this work we have also studied the activation state of the different skin-homing T cell TCR Vb subsets. Of all the five different TCR Vbs analysed in both CLA þ and CLA ¹ populations we only found a significant increase of circulating CLA þ Vb5.1 þ HLA-DR þ in patients with active AD. The active AD group was the only one where Sa colonization was found, in seven of the 12 subjects. The degree of Sa infection in these patients was very heterogeneous ranging from 10 to 20 000 c.f.u. For these reasons and also because of the low number of patients evaluated, it is difficult to derive any conclusion between the degree of infection and the percentage of circulating CLA þ CD3 þ cells in patients with active AD and Sa infection. The only significant correlation found was between the degree of infection and the percentage of circulating CLA þ CD3 þ in those patients with active AD and Sa infection.
It has recently been shown in mice that the presence of antigen-specific tissue-activated T lymphocytes in peripheral blood depends on the time of the initial activation [32] . Thus, 4 h after antigen application specific T lymphocytes disappear from peripheral blood and over the next 4-8 h from the antigen injection the number of antigenspecific T lymphocytes rise. Coinciding with this peak, antigen-specific T lymphocytes start to accumulate in the tissue where the antigen was originally applied. Also a recent report in asthmatic patients showed that, after allergen inhalation, a depletion of circulating allergenspecific T lymphocytes was measured 24 h after the allergen exposure [33] . In our case the time of initiation of infection by Sa is not known and this may be the reason for the low degree of correlation between the Sa infection and TCR expression and activation state. For this purpose a more homogeneous patient population would provide clearer information.
In summary, our data indicate that patients with active AD, but not non-active AD or controls, manifested the following features: elevated percentage of circulating CLA þ CD3 þ cells, colonization of skin lesions by Sa, and an increased percentage of CLA þ lymphocytes with Sa-related TCR Vb segments. Since, both Sa superAgs and CLA þ T lymphocytes are present in the same cutaneous microenvironment in active AD our data suggest that Sa superAgs may be modulating the CLA þ T-cell activation and response. However, in vitro studies with purified skin-homing T cells will be necessary to determine the exact role of this interaction regarding allergen response and cytokine production.
